I would like to let @OP, @ecoool2, @wombat777 and @vinn decide between themselves, as The yankee is not in. My only concern is the actual production capacity. They need the product now. If approved, every hospital in US, at least, will scream for our cells. The rest will be history, with CHF, CLBP coming and AGVHD in the bag. I also see a big fight at the table between FDA, US gov, big pharma and MSB. They want at least a piece of action/ collaboration or a TO (I hope not under $100).
A Bigger Cash Cow for Revascor?, page-25
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |